where: Rv - (C1 - C4)-alkyl; R6 - H or OH; Z - the group (CH2)n where: when n = 0 then T - group of the formula (IV) where p = 2-3, R - (C1 - C3)-alkyl; when n = 1 then T - group of the formula (V) where p' and p'' = 3-4; when n = 2 then T - group of the formula (VI) where p = 2-3, or their acid-additive pharmaceutically acceptable salts. Intermediate compounds of the formula where: R - (C1 - C3)-alkoxy-group; Rv and Z - as indicated above, and pharmaceutical composition based on compounds of the formula (I). Compounds of the formula (I) were synthesized by interaction of amine of the formula (II) with compound of the formula (III) . When compound of the formula (I) is synthesized where R6 - OH then intermediate compound of the formula (I) reacts with hydrogen halide acid. Synthesized compounds were used in pharmacy. EFFECT: improved method of synthesis. 7 cl, 3 tbl"/>
3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION
首页>
外国专利>
3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION
3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION
FIELD: organic chemistry. SUBSTANCE: product: 3-aminopyridazine derivatives of the formula (I) where: Rv - (C1 - C4)-alkyl; R6 - H or OH; Z - the group (CH2)n where: when n = 0 then T - group of the formula (IV) where p = 2-3, R - (C1 - C3)-alkyl; when n = 1 then T - group of the formula (V) where p' and p'' = 3-4; when n = 2 then T - group of the formula (VI) where p = 2-3, or their acid-additive pharmaceutically acceptable salts. Intermediate compounds of the formula where: R - (C1 - C3)-alkoxy-group; Rv and Z - as indicated above, and pharmaceutical composition based on compounds of the formula (I). Compounds of the formula (I) were synthesized by interaction of amine of the formula (II) with compound of the formula (III) . When compound of the formula (I) is synthesized where R6 - OH then intermediate compound of the formula (I) reacts with hydrogen halide acid. Synthesized compounds were used in pharmacy. EFFECT: improved method of synthesis. 7 cl, 3 tbl
展开▼
机译:领域:有机化学。物质:产品:式(I)的3-氨基哒嗪衍生物其中:R v Sub>-(C 1 Sub>-C 4 Sub>)-烷基; R 6 Sub>-H或OH; Z-组(CH 2 Sub>) n Sub>其中:当n = 0时,T-公式(IV)的组其中p = 2-3,R-(C 1 Sub>-C 3 Sub>) -烷基;当n = 1时,则T-公式(V)的组其中p'和p ''= 3-4;当n = 2时,则T-公式(VI)的组其中p = 2- 3,或其酸加成的药学上可接受的盐。公式为<图像文件=“ 00000006.GIF” he =“ 22” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 41” />的中间化合物其中:R -(C 1 Sub>-C 3 Sub>)-烷氧基;如上所述的R v Sub>和Z-以及基于式(I)化合物的药物组合物。通过式(II)的胺的相互作用合成式(I)的化合物。<图像文件=“ 00000007.GIF” he =“ 14” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 14” />加上式(III)的化合物。当合成其中R 6- Sub> -OH的式(I)化合物时,式(I)的中间体化合物与卤化氢酸反应。合成的化合物用于药学。效果:改进的合成方法。 7厘升,3汤匙
展开▼